[go: up one dir, main page]

CN1323724C - 获得2－18f－氟－2－脱氧－d－葡萄糖(18f－fdg)溶液的方法 - Google Patents

获得2－18f－氟－2－脱氧－d－葡萄糖(18f－fdg)溶液的方法 Download PDF

Info

Publication number
CN1323724C
CN1323724C CNB03809035XA CN03809035A CN1323724C CN 1323724 C CN1323724 C CN 1323724C CN B03809035X A CNB03809035X A CN B03809035XA CN 03809035 A CN03809035 A CN 03809035A CN 1323724 C CN1323724 C CN 1323724C
Authority
CN
China
Prior art keywords
deoxy
fluoro
fdg
buffer
glucose solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB03809035XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1646175A (zh
Inventor
彼得勒斯·S·克鲁伊杰
赫克托·H·奈特卡斯特罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of CN1646175A publication Critical patent/CN1646175A/zh
Application granted granted Critical
Publication of CN1323724C publication Critical patent/CN1323724C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB03809035XA 2002-04-24 2003-04-23 获得2－18f－氟－2－脱氧－d－葡萄糖(18f－fdg)溶液的方法 Expired - Fee Related CN1323724C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076638.2 2002-04-24
EP02076638A EP1356827A1 (fr) 2002-04-24 2002-04-24 Préparation d'une solution de 2-18F-fluoro-2-déoxy-D-glucose (18F-FDG)

Publications (2)

Publication Number Publication Date
CN1646175A CN1646175A (zh) 2005-07-27
CN1323724C true CN1323724C (zh) 2007-07-04

Family

ID=28685968

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB03809035XA Expired - Fee Related CN1323724C (zh) 2002-04-24 2003-04-23 获得2－18f－氟－2－脱氧－d－葡萄糖(18f－fdg)溶液的方法

Country Status (13)

Country Link
US (1) US8182788B2 (fr)
EP (2) EP1356827A1 (fr)
JP (2) JP5132869B2 (fr)
KR (1) KR20050005456A (fr)
CN (1) CN1323724C (fr)
AT (1) ATE422903T1 (fr)
AU (1) AU2003225124B2 (fr)
CA (1) CA2483181C (fr)
DE (1) DE60326220D1 (fr)
IL (2) IL164805A0 (fr)
NO (1) NO329160B1 (fr)
PL (1) PL371682A1 (fr)
WO (1) WO2003090789A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
EP1894577A4 (fr) * 2005-06-14 2012-03-28 Nihon Mediphysics Co Ltd Agent d'imagerie pour diagnostic radioactif
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
KR20090025282A (ko) * 2006-06-21 2009-03-10 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물
EP2029182A2 (fr) 2006-06-21 2009-03-04 GE Healthcare AS Stabilisation de précurseurs radiopharmaceutiques
JPWO2008056481A1 (ja) * 2006-11-09 2010-02-25 日本メジフィジックス株式会社 放射性画像診断剤
WO2008075522A1 (fr) * 2006-12-21 2008-06-26 Nihon Medi-Physics Co., Ltd. Agent d'imagerie de diagnostic radioactif
ES2421886T3 (es) 2007-02-13 2013-09-06 Nihon Mediphysics Co Ltd Método para producción de un agente de representación de imágenes de diagnóstico por radiación
CN101903381A (zh) * 2007-10-24 2010-12-01 日本医事物理股份有限公司 对淀粉样蛋白具有亲和性的新化合物
TW200922628A (en) * 2007-10-30 2009-06-01 Nihon Mediphysics Co Ltd Use of novel compound having affinity for amyloid, and process for production of the same
AU2008319985A1 (en) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
WO2009059977A1 (fr) * 2007-11-07 2009-05-14 Ge Healthcare Bv Stabilisation de produits radiopharmaceutiques
ES2770364T3 (es) 2009-04-15 2020-07-01 Lantheus Medical Imaging Inc Estabilización de composiciones radiofarmacéuticas utilizando ácido ascórbico
US9345792B2 (en) 2010-08-13 2016-05-24 Siemens Medical Solutions Usa, Inc. Formulation, apparatus and method for stabilizing radiopharmaceuticals
CN108218650A (zh) 2010-12-29 2018-06-29 通用电气健康护理有限公司 洗脱溶液
US20130004414A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
US20130005958A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
CN109966515A (zh) * 2011-12-21 2019-07-05 通用电气健康护理有限公司 在柠檬酸盐缓冲液中的18F-Fluciclovine组合物
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
FR3054445B1 (fr) * 2016-07-26 2019-07-05 Laboratoires Cyclopharma Synthese d'une composition d'agent radioactif
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
GB202005282D0 (en) 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
WO1998015295A2 (fr) * 1996-10-07 1998-04-16 Dupont Pharmaceuticals Company Produits radiopharmaceutiques servant a prendre l'image d'une infection ou d'une inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002117L (sv) * 1990-06-14 1991-08-26 Nils Elander Mikrovaagsanordning foer behandling av precessvaetskor
JP3370666B2 (ja) 1990-07-06 2003-01-27 マリンクロッド・インコーポレイテッド 放射性レニウム錯体溶液の調製法
JPH0797340A (ja) * 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
BE1010280A3 (fr) 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
WO1998015295A2 (fr) * 1996-10-07 1998-04-16 Dupont Pharmaceuticals Company Produits radiopharmaceutiques servant a prendre l'image d'une infection ou d'une inflammation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Aspects of the Preparationof18F-F-2-deocy-2-fluoro-D-glucose(18FDG) for medical use, Irie T et al,Radioisotopes. Japan,Vol.31 No.1 1982 *

Also Published As

Publication number Publication date
NO20045070L (no) 2004-11-22
CN1646175A (zh) 2005-07-27
EP1356827A1 (fr) 2003-10-29
CA2483181C (fr) 2011-06-28
PL371682A1 (en) 2005-06-27
DE60326220D1 (de) 2009-04-02
ATE422903T1 (de) 2009-03-15
AU2003225124B2 (en) 2007-06-14
JP2010248244A (ja) 2010-11-04
NO329160B1 (no) 2010-08-30
IL164805A (en) 2009-06-15
WO2003090789A1 (fr) 2003-11-06
JP2006500319A (ja) 2006-01-05
EP1496946A1 (fr) 2005-01-19
JP5132869B2 (ja) 2013-01-30
US8182788B2 (en) 2012-05-22
AU2003225124A1 (en) 2003-11-10
CA2483181A1 (fr) 2003-11-06
IL164805A0 (en) 2005-12-18
US20050175536A1 (en) 2005-08-11
EP1496946B1 (fr) 2009-02-18
KR20050005456A (ko) 2005-01-13

Similar Documents

Publication Publication Date Title
CN1323724C (zh) 获得2－18f－氟－2－脱氧－d－葡萄糖(18f－fdg)溶液的方法
JP3547755B2 (ja) オキサリプラティヌムの医薬的に安定な製剤
EA013324B1 (ru) Фармацевтические композиции бендамустина, предназначенные для лиофилизации
US20100087392A1 (en) Complexes of ibuprofen, cyclodextrins and ternary agents and the use thereof in pharmaceutics
JPH05503940A (ja) 新規インスリン組成物
JP3200604B2 (ja) 菌体内毒素誘発作用抑制方法
CN101541324B (zh) 医药组合物
JPH0525857B2 (fr)
JP2016528261A (ja) クロロゲン酸粉末注射剤及びその製造方法
JP3699223B2 (ja) ヒドロキソコバラミンの新規投与形態およびそれの青酸中毒における使用
JPH03167127A (ja) 抗血栓作用を有する硫酸化グリコサミノグリクロナン
AU2007262496A1 (en) Pharmaceutical composition for injectional, particularly targeted local administration
EP1575621B1 (fr) Formulations de milieu de contraste présentant une tolérance biologique ameliorée
CN101756912B (zh) 一种蛇毒凝血酶冻干粉针剂及其制备方法
WO2018102145A1 (fr) Formulations liquides de lévothyroxine
CN114685389B (zh) 一种基于迈克尔加成的pet显像剂、制备方法与用途
KR101850479B1 (ko) [18F]플루오로-도파의 중성 pH 안정화 방법
CN110314132B (zh) 一种门冬氨酸鸟氨酸注射液及其制备方法
CN116549384A (zh) 一种高浓度大蒜素组合物注射液及其制备工艺
CN1927206A (zh) 氯诺昔康注射用组合物及其制备方法
DE68906027T2 (de) Cyclodextrimpeptid-einschlusskomplexe.
WO2005065705A1 (fr) Preparation de seringue pre-remplie de calcitonines

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070704

Termination date: 20100423